Montreal - Whether caused by an infection or a drug, severe cutaneous reactions must be quickly identified and treated, as many are associated with significant morbidity and mortality.
FDA Issues Complete Response Letter for Abeona's Pz-cel for Epidermolysis Bullosa
The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment
Tristan Hasbargen, PA-C: Closure Types in Mohs Surgery and More
ReV Up Your Vitiligo Treatment Strategies
QUIZ: Test Your Knowledge of Rosacea Treatment Modalities and the Therapeutic Landscape
European Union Approves Bimekizumab to Treat HS